Can a pharmaceutical manufacturer face liability for failing to bring an allegedly safer drug to market sooner, even when the drug it already sells is not defective?
Husch Blackwell leads our clients from where they are to where they want to be. From offices in 18 U.S. cities, we deliver legal insight and business leadership that helps our clients identify smart solutions, advance their goals and move forward.
On October 7, 2026, United States Assistant Attorney General Colin M. McDonald issued Directive 26-13, “A Comprehensive Approach in the Fight Against Fraud,” (Comprehensive Approach Memo) to all personnel in the Department of Justice’s (DOJ) National Fraud Enforcement Division.…
Key point: The NSA and CISA have urged immediate patches for two critical PHP vulnerabilities. Here are six questions to guide your discussion with IT.
Two critical PHP vulnerabilities, CVE-2026-109618 and CVE-2026-109619, collectively referred to as “PHP2Shell,” can permit unauthenticated…
On Friday, October 23, President Trump issued a Proclamation (the Proclamation) modifying the scope of products from Canada subject to Section 338 tariffs. Please see our previous post on Section 338 tariffs here.…
We just released Episode 49 of the False Claims Act Insights podcast where Lorinda Holloway and I talk about whether insurance can cover False Claims Act investigations and settlements.
Many executives assume fraud exclusions make the answer no, but a…
President Trump Issues New Executive Order Waiving Certain Russia Sanctions Imposed Under Graham Act
On Friday, October 16, 2026, President Trump issued an Executive Order implementing the Graham Act, passed back in September 2026. The Order waived most of the…
On September 28, 2026, the Commodity Futures Trading Commission (the CFTC or Commission) submitted two proposed rules to the White House Office of Information and Regulatory Affairs (OIRA) that would further define the term “swap” under the Commodity Exchange Act…